Amy Orcutt has more than 10 years of experience in the health care and medical device industries. Prior to joining Saladax, Amy worked as a quality and regulatory consultant for Fortune 500 companies. Amy has extensive experience in the development and implementation of global regulatory strategies and quality systems management. Amy received her BS degree in chemistry from Stonehill College and her MBA from the University of Memphis.
Current role
Director, Regulatory & Quality at Aristea Therapeutics
Director, Regulatory & Quality Assurance at Kyra Medical
Board Member & Director, Regulatory & Quality at KeriCure
Global Director, Regulatory, Quality, & Clinical Affairs at Invivoscribe
Senior Director, Regulatory & Quality at NUVAIRA